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COVID-19 is the world’s first digital pandemic. 
Digital tools and technologies have been 
developed to track and trace the spread of the 
virus, screen for infection, and the pandemic 
has accelerated the use of digital technology 
in the delivery of healthcare.1 The continued 
development of these tools and technologies, 
the monitoring of the virus and the develop-
ment of new tests, treatments and vaccines 
are dependent on the collection of and 
access to vast amounts of personal data. This 
includes clinical data, epidemiological data 
and public health data that may be collected 
from laboratories, medical records, wearables 
and smartphone apps. Previous public health 
emergencies (PHEs) have demonstrated 
the importance in making this data avail-
able,2 and early in the COVID-19 pandemic, 
there were calls for making all kinds of data, 
including clinical trial data, routine surveil-
lance data, genetic sequencing, and data on 
the ongoing monitoring of disease control 
programmes, openly and rapidly available.3 
As part of this, personal data on age, race, 
sex, health, ethnic group, and socioeconomic 
factors have been shared. This has helped led 
to the rapid development of COVID-19 inter-
ventions. It has also enabled the better under-
standing of factors contributing to difference 
in infection rates and effectiveness of tests, 
treatments, and vaccines. However, the use 
of this particularly sensitive data can infringe 
upon individual and group privacy, increase 
the risks of individual and group stigma and 
discrimination, and it may negatively impact 
already vulnerable, marginalised or minority 
populations.4
During this pandemic, states of emer-
gency have been declared, and many of our 
fundamental rights including our right to 
privacy have been limited as part of national 
COVID-19 responses.5 Such an approach 
can be appropriate in a democratic society, 
but policies that relied on public trust 
have resulted in increased compliance and 
improved public health outcomes.6 Thus it 
is not always a binary choice between privacy 
and an effective public health response. The 
focus should be on how best to safeguard 
our privacy interests and foster public trust 
in the ongoing access to data and use of 
digital technologies, even when our right to 
privacy has been limited.7 As we have learnt 
from previous PHEs, trust is not a concept 
on which to ground data practices, as this is a 
breeding ground for exploitation. Rather it is 
the transparent and accountable governance 
of data use and digital technologies that can 
foster this public trust.8
The Access to COVID-19 Tools Accelerator 
(ACT- Accelerator) was established to respond 
to the COVID-19 pandemic by scaling up the 
development and equitable distribution of 
tests, treatments and vaccines, and strength-
ening underlying health systems infrastruc-
ture. Early in its work, the R&D and Digital 
Working Group of the ACT- Accelerator 
Summary box
 ► COVID-19 is the world’s first digital pandemic with 
the use of digital technologies and personal data 
central to our response.
 ► The use of these data must be appropriately gov-
erned to ensure its use is in the public interest.
 ► The Framework for the Governance of Personal Data 
for the Access to COVID-19 Tools Accelerator pro-
vides a principle- based approach, implemented in a 
procedural guidance to govern the use of COVID-19 
personal data.
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Diagnostics Pillar recognised that to achieve this goal, the 
collection, linking, sharing, and timely access to data is 
essential, but these data use must be supported by a clear 
and transparent governance framework rooted in human 
rights. The Framework for the Governance of Personal 
Data for the Access to COVID-19 Tools Accelerator was 
thus developed. It is to promote best practice and the 
responsible use of personal data by all initiatives funded 
under the ACT- Accelerator.9
The framework requires that the use of personal data 
in responding to COVID-19 must be done in a manner 
that safeguards privacy and the rights of vulnerable 
groups. This vulnerability may be due to the global 
context of inequality and asymmetries of power, but 
equally may arise due to comorbidities, identity, personal 
circumstances or the use of personal data without due 
consideration of possible harms. Within this context, the 
framework identifies key principles that should underpin 
data use that are implemented in a procedural guideline: 
six substantive principles (solidarity, respect for persons 
and communities, equity, non- exploitation, privacy, and 
data stewardship) are to guide any decisions on data and 
data use, and three procedural principles (transparency, 
accountability, and engagement) must guide the process 
of decision making. These principles must be read 
together to provide overarching guidance on managing 
personal data during COVID-19, but also on balancing 
the collective interests in responding to COVID-19 
with our individual rights. To assist in this, the frame-
work provides detailed guidance on data management, 
including data collection and storage, data retention, 
data access, and the responsibilities of those processing 
personal data during COVID-19.
In developing this framework, we were cognisant that 
the impact of COVID-19 is unequal due to the global 
context of inequality and asymmetries of power and also 
that data practices in the past have been exploitative and 
perpetuate global health inequity.10 We were aware that 
data practices adopted during COVID-19 will be influen-
tial in any pandemic preparedness and future pandemic 
response and the importance of adopting practices now 
that drive an equitable global response. Thus, the frame-
work requires the equitable access to data and equitable 
access to any tests, treatments and vaccines that are 
developed from this data. Adopting and building on the 
practices set out in the framework can provide a more 
equitable response in future digital pandemics.
Experience has taught us that the governance of this 
personal data must extend to its use in a postpandemic 
world. We must guard against the unethical and exploit-
ative practices of past PHEs that saw access to data by 
the local data collectors denied after the pandemic had 
ended.8 The personal data collected during COVID-19 is 
essential for our response now, but it will also be a valu-
able resource for better understanding our response, 
guiding pandemic preparedness, as well as other 
research. We must ensure that these personal data are 
available for research, but be mindful that the conditions 
under which the data were collected will have changed. 
We will no longer be in an emergency situation, and deci-
sions on the most appropriate use of these data will need 
to be made. Such conversations will likely take place at 
a global level, but it is crucial that they take account of 
national interests. With this in mind, the framework calls 
for the establishment of national independent Data Stew-
ardship Oversight Committees for COVID-19. During 
the pandemic they should monitor the collection and 
use of personal information and ensure that it is in line 
with public expectations, human rights and clear and 
accountable processes. In a post- COVID-19 world, these 
national committees should be tasked with determining 
access to COVID-19 data, the conditions for access, but 
importantly ensure that decisions on access continue 
to be driven by public and not private or commercial 
interests.
As we move through this pandemic, we are continually 
reminded of the importance of pandemic preparedness.11 It 
is crucial that we learn lessons from this digital pandemic and 
have appropriate governance to guide the use of personal 
data in future pandemics. The ACT- Accelerator Data Gover-
nance Framework provides a starting point. We therefore 
welcome all COVID-19 related consortia, research, and other 
initiatives that are using COVID-19 personal data to adopt 
and use this framework. This framework is a living document 
and will be updated and refined based on recommendations 
and experiences with its implementation and we encourage 
feedback to be sent to the ACT- Accelerator Diagnostics Pillar 
( ACTAdiagnostics@ finddx. org). It is through this sharing of 
learnt experiences that we will find ourselves better informed 
and better prepared to respond to our next global pandemic.
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